Regulation of RLR-mediated innate immune signalingit is all about keeping the balance
Important considerations when combining HRT and GLP-1 Before starting or combining HRT and GLP-1, there are several factors to discuss with a clinician: Not all HRT formulations are the same: Transdermal estrogen and micronized progesterone are often preferred when combining with other medications Individual risk factors matter: History of certain cancers, cardiovascular issues, or blood clots affects HRT suitability Monitoring is important: Regular check-ins help ensure both treatments are working well together Timing and dosing: A clinician can help determine whether to start treatments simultaneously or sequentially A personalized approach to weight loss during hormonal changes Because every body responds differently to hormonal shifts and medications, personalized care makes a meaningful difference in outcomes
Other side effects Additional reported side effects include: Joint pain and water retention Muscle and joint aches Headaches and nausea Receptor desensitization with prolonged use Potential suppression of natural GH and IGF-1 production Who should avoid IGF-1 LR3 Certain groups should not use IGF-1 LR3: Anyone with active cancer or tumor history Those with severe insulin resistance or diabetes Pregnant or nursing women Anyone under 25 whose growth plates haven't closed Those with existing hormonal imbalances IGF-1 LR3 is not FDA-approved for general medical use and remains primarily a research compound
Retatrutide reduces thirst perception while GI symptoms can cause fluid loss
Core Breakthrough Strategies for Peptide Products 1
For Wegovy to work effectively as intended, take the medication at around the same time, in the same way each day
